Thursday, July 30, 2020
Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing
Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
A look at India's Svamitva Scheme, which has digitally mapped out landholdings using drones in 300K+ villages as of January 2025, as concerns mount over errors (Scroll.in)
Scroll.in : A look at India's Svamitva Scheme, which has digitally mapped out landholdings using drones in 300K+ villages as of Janua...
-
Jake Offenhartz / Gothamist : Since October, the NYPD has deployed a quadruped robot called Spot to a handful of crime scenes and hostage...
-
Lorena O'Neil / Rolling Stone : A look at the years of warnings about AI from researchers, including several women of color, who say ...
No comments:
Post a Comment